In the context of melanoma, we showed that PDC*line cells loaded with peptides derived from four melanoma-associated antigens activated the rare tumor ASTCs present in the blood and, more importantly, in the tumors of patients [15,16]. This evidence concerns the gene PDC and neoplasm.